TAL News Alert Tal International Group (TAL) 41.00 02/14/2015

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Tal International Group (TAL) 41.00 $TAL

TAL International Group's (TAL) CEO Brian Sondey on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Feb 12, 11:59AM CST

TAL: 41.00 (+0.37)

TAL International declares $0.72 dividend
Seeking Alpha - at Seeking Alpha - Wed Feb 11, 4:39PM CST

TAL: 41.00 (+0.37)

TAL International Group, Inc. Reports Fourth Quarter and Full Year 2014 Results and Declares $0.72 Quarterly Dividend
Business Wire - Wed Feb 11, 4:22PM CST
TAL International Group, Inc. (NYSE:TAL), one of the world's largest lessors of intermodal freight containers and chassis, today reported results for the fourth quarter and full year ended December 31, 2014.
TAL: 41.00 (+0.37)

TAL International beats by $0.01, misses on revenue
Seeking Alpha - at Seeking Alpha - Wed Feb 11, 4:11PM CST

TAL: 41.00 (+0.37)

Notable earnings after Wednesday's close
Seeking Alpha - at Seeking Alpha - Tue Feb 10, 4:35PM CST

TSLA: 203.77 (+0.89), ITRI: 35.75 (-0.12), PNRA: 155.02 (-2.31), SKX: 66.09 (-0.06), STMP: 56.92 (-0.24), ZEN: 25.38 (+1.02), SLF: 31.31 (-0.09), FET: 18.70 (+2.61), HOS: 20.45 (+1.52), HIVE: 4.26 (+0.15), AEM: 32.61 (+0.10), CAKE: 48.22 (-1.04), AMAT: 24.12 (-0.02), CSCO: 29.43 (-0.03), WFM: 56.15 (-0.15), CJES: 12.98 (+1.36), HNI: 53.44 (+2.60), IO: 2.54 (+0.02), GAS: 50.07 (+0.27), QDEL: 25.18 (+0.35), CSOD: 35.03 (+2.02), EXL: 13.74 (-0.08), NVDA: 22.31 (+0.01), DDR: 19.41 (-0.28), NTWK: 5.14 (-0.11), AMBR: 8.37 (+0.13), CPA: 119.12 (+0.27), FORR: 37.58 (-0.03), AUY: 4.13 (+0.13), CTL: 39.46 (+0.17), ACHC: 63.20 (-0.45), OII: 50.47 (+0.59), NU: 51.02 (-1.28), CVA: 21.45 (+0.64), PPC: 26.75 (+0.77), REG: 66.77 (-0.46), TAL: 41.00 (+0.37), SWM: 43.15 (-0.86), Z: 106.50 (+1.75), FEYE: 42.26 (+2.63), ABCO: 53.69 (+0.32), TCX: 18.30 (-0.13), DIOD: 27.81 (-0.32), MET: 50.86 (+0.53), SPRT: 1.78 (+0.04), TRIP: 84.81 (+2.41), CYS: 8.78 (+0.04), NSIT: 25.92 (+1.31), TTGT: 11.90 (+0.60), NTAP: 38.22 (+1.32), EFX: 92.56 (-0.18), CRAY: 32.65 (+0.24), LPSN: 10.74 (+0.38), BIDU: 212.13 (+7.11), TSO: 81.92 (+0.50), CXW: 39.92 (+0.72), SCSS: 32.14 (+0.43), EFC: 20.75 (-0.01)

Data Analytics Is Good Business - Cramer's Lightning Round (2/9/15)
SA Editor Mohit Manghnani - Seeking Alpha - Tue Feb 10, 5:36AM CST
Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Monday, February 9. Bullish Calls: Bristol-Myers Squibb (NYSE: BMY ): " Bristol-Myers is fine. You need to take a long-term view on it." Frontier...
STR: 24.09 (-0.08), VRSK: 67.90 (+0.46), IBM: 160.40 (+1.88), NUE: 48.90 (+0.55), TAL: 41.00 (+0.37), BMY: 60.04 (+0.56), DATA: 99.90 (+1.40), X: 26.36 (+1.12)

'Mad Money' Lightning Round: Take Nucor Over United States Steel
at The Street - Tue Feb 10, 5:00AM CST
Cramer continues to recommend Bristol-Myers Squibb but wants you to be careful on TAL International.
FTR: 8.38 (+0.01), VRSK: 67.90 (+0.46), NUE: 48.90 (+0.55), TAL: 41.00 (+0.37), BMY: 60.04 (+0.56), X: 26.36 (+1.12)

Jim Cramer's 'Mad Money' Recap: Stop Worrying About the Fed Rate Increase
at The Street - Mon Feb 09, 7:53PM CST
History tells us that growth and progress are positives for the stock market, Cramer says, and this time will be no different.
FTR: 8.38 (+0.01), NUE: 48.90 (+0.55), WFC: 55.33 (+0.47), BMY: 60.04 (+0.56), XLU: 45.17 (-0.70), AB: 27.17 (+0.47), VRSK: 67.90 (+0.46), RIG: 19.05 (+0.42), GILD: 101.90 (+1.10), MPC: 103.48 (+2.08), MRO: 29.49 (+0.71), TAL: 41.00 (+0.37), TWTR: 48.50 (+0.55), X: 26.36 (+1.12)

Buy-Rated Dividend Stocks: Top 3 Companies: TAL, BPL, EEP
at The Street - Fri Feb 06, 9:30AM CST
These 3 dividend stocks are rated a Buy by TheStreet
BPL: 74.72 (+0.09), TAL: 41.00 (+0.37), EEP: 38.84 (-0.50)

DGI 2015 Candidate Buy List - Industrials Sector
Earl Setser - at Seeking Alpha - Tue Feb 03, 6:57PM CST

E: 36.31 (+0.69), LMT: 196.95 (-0.53), GE: 25.15 (+0.26), ABB: 21.34 (+0.27), ETN: 72.55 (+0.90), EMR: 58.68 (+0.08), RSG: 39.34 (-1.67), TAL: 41.00 (+0.37), CAT: 85.13 (+1.60), AVX: 13.95 (+0.29)

TAL International Group Announces Dates for Fourth Quarter and Full Year 2014 Earnings Release and Conference Call
Business Wire - Thu Jan 29, 2:24PM CST
TAL International Group, Inc. (NYSE:TAL) today announced that it will report its financial results for the fourth quarter and full year ended December 31, 2014 after the market closes on Wednesday, February 11, 2015. The earnings release and an updated investor presentation will be available on the Company's website at that time.
TAL: 41.00 (+0.37)

Best Of The Buy-Rated Dividend Stocks: Top 3 Companies: LAMR, TAL, UFS
at The Street - Tue Jan 20, 9:30AM CST
These 3 dividend stocks are rated a Buy by TheStreet
UFS: 44.99 (-0.10), LAMR: 57.55 (+0.16), TAL: 41.00 (+0.37)

10 Dividend Growth Stocks For January 2015
FerdiS - at Seeking Alpha - Tue Jan 13, 4:20PM CST

HP: 69.58 (+3.62), TGH: 33.45 (-0.27), MO: 54.76 (-0.78), TUP: 72.53 (+0.44), STWD: 24.24 (-0.10), JNJ: 99.62 (+1.18), PM: 82.87 (-0.82), T: 34.66 (+0.05), AVA: 33.95 (-0.52), IBM: 160.40 (+1.88), DOV: 74.41 (+1.13), TAL: 41.00 (+0.37), CAT: 85.13 (+1.60), BBL: 48.82 (+2.36), DOW: 49.44 (+0.29)

401(k) Reconstructed: 2014 Portfolio Review
Eric Landis - at Seeking Alpha - Mon Jan 12, 7:19AM CST

COH: 39.85 (+0.64), IBM: 160.40 (+1.88), TAL: 41.00 (+0.37), OXY: 83.11 (+1.07)

3 Buy-Rated Dividend Stocks: TAL, TOT, SNH
at The Street - Thu Jan 08, 9:30AM CST
These 3 dividend stocks are rated a Buy by TheStreet
TOT: 54.14 (-0.36), TAL: 41.00 (+0.37), SNH: 22.47 (+0.36)

Insider Trading Alert - TAL, CRM And PRI Traded By Insiders
at The Street - Tue Jan 06, 9:45AM CST
Stocks with insider trader activity include TAL, CRM and PRI
PRI: 55.09 (+0.55), TAL: 41.00 (+0.37), CRM: 62.85 (+1.59)

YieldBoost TAL From 6.7% To 16.7% Using Options
at The Street - Tue Dec 23, 10:58AM CST
Shareholders of Tal International Group Inc looking to boost their income beyond the stock's 6.7% annualized dividend yield can sell the April 2015 covered call at the $45 strike and collect the premium based on the $1.35 bid, which annualizes to an...
TAL: 41.00 (+0.37)

Dividend Challengers: 24 Increases Expected By February 28
David Fish - at Seeking Alpha - Sat Dec 13, 2:17PM CST

HOG: 63.90 (+0.82), LAZ: 50.90 (+0.18), AIV: 38.55 (-0.50), CNP: 21.76 (-0.35), AIT: 42.60 (+0.09), UPS: 101.79 (+0.38), SLB: 88.38 (+2.42), PRI: 55.09 (+0.55), VLO: 58.60 (+2.05), MAT: 27.61 (+0.17), AJG: 47.50 (+0.27), MMLP: 30.17 (+0.19), HME: 67.76 (-0.96), MWE: 60.94 (+1.13), RES: 13.36 (+0.93), INGR: 82.82 (+0.59), PFE: 34.64 (-0.23), ALL: 71.46 (-0.11), CLB: 112.18 (+3.65), RAS: 7.38 (+0.06), MCO: 98.22 (+0.01), FLIR: 33.01 (-0.23), SMP: 39.33 (-0.14), CPA: 119.12 (+0.27), ARCP: 9.40 (+0.06), HEI: 62.50 (+0.89), EWBC: 40.60 (+0.37), MKTX: 81.22 (-0.66), SNI: 73.00 (+0.39), BCPC: 58.18 (+0.84), FCF: 8.62 (-0.10), GMT: 60.08 (-0.44), ALE: 53.65 (-1.17), TAL: 41.00 (+0.37), EMCF: 24.03 (-0.87), WDR: 49.94 (+0.15), TLLP: 55.75 (-0.07), EPR: 61.68 (-0.30), EME: 43.70 (+0.61), PCBK: 13.44 (-0.04), X: 26.36 (+1.12), CMS: 34.65 (-0.88), LGCY: 13.35 (+0.51), CUBE: 24.28 (-0.32), AMGN: 153.48 (+0.30), EFX: 92.56 (-0.18), ATK: 140.03 (+0.78), FINL: 23.51 (-0.32), LEA: 108.70 (-0.73), TESS: 25.19 (+0.29), LB: 94.51 (-0.30), HPY: 49.42 (-5.71), DNB: 133.27 (+0.46), BIP: 46.20 (-0.21), TOO: 20.51 (+0.25), FIBK: 26.15 (+0.06), CNA: 43.40 (+0.18), MOFG: 28.75 (-0.48)

Growth In Global Trade Opens Investment Opportunity In Shipping Container Stocks
Small Cap Reporter - at Seeking Alpha - Mon Dec 01, 3:59AM CST
The need for global maritime logistics has become more important with companies like Alibaba (NYSE: BABA ) and Amazon (NASDAQ: AMZN ) breaking barriers to global commerce in becoming industry juggernauts for international trade. Most exports of...
TAL: 41.00 (+0.37), TGH: 33.45 (-0.27), CAP: 24.72 (-0.61)

Textainer: A 5.4% Yield Plus A Play On Chinese Growth
Albert Alfonso - Seeking Alpha - Fri Nov 28, 11:25AM CST
It has been a while since I last discussed Textainer Group Holdings (NYSE: TGH ). The company is the world's largest container lessor controlling with its 2 million containers and 3.2 million TEU of capacity. The company has come under pressure in...
TGH: 33.45 (-0.27), TAL: 41.00 (+0.37)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

TechCrunch Disrupt 2026: NYSE and Snowflake Highlights

Updated Category News Views 21

Ever noticed how the air vibrates just a bit more when major players like NYSE and Snowflake start shaking hands at big-league events like TechCrunch Disrupt? You'd better believe we're seeing a fresh brew of opportunities and challenges in the market as these titans lock horns and share insights. It's no small feat when the financial nerve center partners into the tech...

Continue Reading
Paradigm Therapeutics: A Beacon in Rare Diseases

Updated Category News Views 4

A Step Towards Recognition You know the old saying: innovation never sleeps. Well, Paradigm Therapeutics seems to have taken that to heart. The company's embarked on a peculiar yet promising journey with SD-101 (Zorblesia™), and here they are, basking in the glow of another nomination for the 2026 Prix Galien USA "Best Start-Up" award. It’s their second shot at this...

Continue Reading
Partner Valuation Advisors Bolsters Team with Eichman

Updated Category News Views 7

Eichman Joins Partner Valuation Advisors as MD Turns out the buzz in real estate appraisal isn’t just about property values these days; it's about who's valuing them. Just ask Partner Valuation Advisors, who are realigning their chess pieces by bringing seasoned pro Justin Eichman, MAI, on board as Managing Director. Talk about playing your cards right. A Heavyweight in...

Continue Reading
Skiptown Expands in Georgia Amid Growing Demand

Updated Category News Views 24

With the pet care industry barking up a storm lately, Skiptown is ramping up efforts to expand its presence in Georgia. The tech-enabled dog care franchise already has a paw print in Atlanta, but it's sniffing out new opportunities across the state. Now they're on the hunt for franchise owners who can bring this modern approach to more communities. Why Georgia? The Growth...

Continue Reading
Think Tank Pushes for Bold Parkinson's Prevention Plan

Updated Category News Views 25

A New Era for Parkinson's Disease Prevention The Parkinson's Foundation has rolled out its battle plan to take on Parkinson's disease from the ground up, shifting gears from managing symptoms to stopping the illness before it starts. It's about damn time, too. With the disease being the fastest-growing neurodegenerative disorder and impacting 10 million people worldwide,...

Continue Reading
Veterans Transitioning to Real Estate with Scholarships

Updated Category News Views 15

Tapping Military Skills for Civilian Gain Finding a new career after military service is a mountain of a task, but veterans now have a golden ticket into the real estate appraisal world. The Appraisal Institute's Next Mission Scholarship is throwing veterans a $1,000 life preserver to dive into a field where their military-honed skills already shine. The Power of a...

Continue Reading
Special Needs Group Partners with MAST to Enhance Accessibility

Updated Category News Views 22

Accessible Travel Takes the Spotlight Ah, the travel biz—just when you think you’ve got it all figured out, along comes a partnership like this to shake things up. Special Needs Group, the big cheese in mobility and medical equipment rentals, is teaming up with MAST Travel Network. Together, they're rolling out initiatives to make the world a bit more accessible, even...

Continue Reading
Omneky Outshines Competitors in AI Ad Scoring

Updated Category News Views 33

Brewing a better ad with AI isn't just about the model you plug in—it's about the wizardry wrapping around it. Omneky's latest caper in the AI advertising game has snagged the spotlight, pulling a hearty 8.8 taste score on a recent TasteBench comparison. That's not a minor tweak, folks, but a whopping 1.2-point lead over the shadow-chasing curves of the next...

Continue Reading
New Data on SKYRIZI Offers Hope for Crohn's Patients

Updated Category News Views 16

Treating Crohn's: New Hope on the Horizon Folks, let me tell you, the landscape for treating Crohn's disease just got a bit more interesting. AbbVie's Phase 3 AFFIRM study has brought some attention-grabbing data on the table, showcasing the potential of their drug, SKYRIZI® (risankizumab-rzaa). This ain't just another run-of-the-mill study; these results could be a...

Continue Reading
Honeywell Aerospace Faces Legal Turbulence in Fraud Case

Updated Category News Views 7

If you've got your chips on Honeywell Aerospace, Inc. (HONA), buckle up because things are getting choppy. Investors who took a bath on their shares now have the chance to put on their legal gloves and join a securities fraud class action lawsuit against the company. Legal Storm Over Misleading Statements Here's the rub: Between June 29 and September 1, 2026, the folks at...

Continue Reading

Top 5 Most Recently Viewed Articles

Pieridae Energy Limited Reports Strong Q3 2024 Performance

Updated Category News Views 58

Strong Financial and Operational Results from Pieridae Energy CALGARY, Alberta - Pieridae Energy Limited (“Pieridae” or the “Company”) (TSX: PEA) has announced its third quarter 2024 financial and operating results, showcasing an impressive production output and robust financial performance. The company achieved a production rate of 23,116 barrels of oil...

Continue Reading
Atea Pharmaceuticals Showcases Promising HCV Treatment Data

Updated Category News Views 136

Innovation in Hepatitis C Treatment by Atea Pharmaceuticals Atea Pharmaceuticals, Inc. (NASDAQ: AVIR) has made a significant impact in the field of antiviral therapeutics through their ongoing research and development efforts. The company recently presented compelling data at The Liver Meeting 2024, highlighting the promising combination of bemnifosbuvir and ruzasvir for...

Continue Reading
Study Confirms Safety of Combined Eye Drops for Surgery Use

Updated Category News Views 172

Introduction to the Study A five-year pharmacovigilance study has confirmed the excellent safety profile of a fixed-dose combination eye drop developed by NTC. This eye drop combines an anti-inflammatory steroid and a quinolone antibiotic, designed for preventing and treating inflammation, as well as preventing infection after cataract surgery. Study Overview The findings...

Continue Reading
New Concerns Arise for Roblox Amid Allegations of Misreported Metrics

Updated Category News Views 203

Allegations Against Roblox: A Closer Look Roblox Corp (NYSE: RBLX) has recently come under fire after a report from Hindenburg Research highlighted potential discrepancies in its reported user metrics, leading to a notable decline in its stock prices. The gaming platform is being questioned for allegedly overstating its user metrics, including daily active users (DAUs)...

Continue Reading
uniQure N.V. Faces Investigation Amid Securities Fraud Concerns

Updated Category News Views 155

Understanding the uniQure N.V. Investigation Currently, uniQure N.V. is under investigation concerning possible violations of securities laws. This inquiry has raised significant concerns for shareholders and potential investors, driving many to seek assistance in understanding their rights moving forward. The investigation is being led by the DJS Law Group, an...

Continue Reading